Nextleaf has recently shared commercial updates, including the introduction of 12 new product listings set to launch between September 2024 and early 2025. Presently, the company produces 40 products for distribution to both medical and adult use consumers nationwide. Notably, their product pipeline showcases a significant expansion into the market for minor cannabinoids.
For additional details, please refer to the full story available via the provided link.
In the realm of cannabis news, the top stories for the week include a cannabis company securing a position on the Report on Business annual Ranking of Canada’s top-growing companies for the fourth consecutive year, the launch of hemp-derived Delta-9 THC-infused Beckett’s Tonics at Total Wine & More locations, and a collaboration between a leading global medical cannabis company on a Genome B.C.-funded project focused on distinct cannabis aromas.
In the sector of top cannabis stocks from September 27 to October 3, 2024, the following companies and their associated views were highlighted:
– T.TLRY | 9,327 views | Tilray Brands Inc.
– C.CURA | 3,963 views | Canopy Growth Corp.
– T.WEED | 2,918 views | Curaleaf Holdings Inc.
– T.LABS | 2,524 views | Medipharm Labs Corp.
– C.OILS | 1,162 views | Nextleaf Solutions Ltd.
– T.OGI | 601 views | OrganiGram Holdings Inc.
It is essential to note that the content provided is for informational purposes only and should not be considered investment advice. For a comprehensive disclaimer, please visit the link provided.
